Treatment and metaphylaxis of respiratory diseases in swine.
REXOVET TLT® is indicated for the treatment and metaphylaxis of respiratory diseases in swine associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Mycoplasma hyopneumoniae, Haemophilus parasuis and Bordetella bronchiseptica that are susceptible to tulathromycin.
Its formulation contains 10% tulathromycin and is administered as a single intramuscular dose, according to the directions for use provided by Vetanco Argentina.
Indicated for the treatment and metaphylaxis of respiratory diseases in swine.
Acts against infections associated with pathogens susceptible to tulathromycin, as described in the indication.
Formulated with tulathromycin at a concentration of 10%.
Administer 1 ml per 40 kg of body weight as a single dose.
Administered intramuscularly according to the directions for use.
Tulathromycin 10%.
Administer 1 ml of REXOVET TLT® per 40 kg of body weight as a single intramuscular dose.
Observe the 14-day withdrawal period stated on the official product page.
50 ml vial.
14 days.